Control groups appropriate for behavioral interventions.
Control groups appropriate for behavioral interventions.
复制标题
适合行为干预的对照组。
DOI：
10.1053/j.gastro.2003.10.038
复制
发表时间：
2004
期刊：
影响因子：
29.4
通讯作者：
Whitehead,WilliamE
中科院分区：
文献类型：
--
作者：
Whitehead,WilliamE
There are 4 sources of bias in clinical trials: investigator bias, patient expectation (placebo response), ascertainment bias (inadvertent selection of an unrepresentative sample), and nonspecific effects such as the normal waxing and waning of symptoms over time and the quality of the doctor-patient relationship. In drug trials, these biases are adequately controlled by comparing active to inert pills, randomly assigning subjects to treatments, blinding both the investigator and subject to group assignment, and testing subjects at multiple sites. However, there are special problems with conducting clinical trials of behavioral or psychological interventions that render these controls inadequate. It is impossible to blind the experimenter to which treatment is active, it is difficult to identify a control treatment that is inactive but just as credible to the subject, and doctor-patient relationship variables are more important than in drug trials. The inability to blind the experimenter can be circumvented by having an independent, blinded investigator assess the outcome, and doctor-patient effects can be controlled by using multiple, experienced therapists. The most difficult problem, identifying an appropriate control treatment, can be solved by adhering to 2 principles: the control treatment should be plausible, and it should not have a significant impact on the mechanism that is thought to explain the effectiveness of the investigational treatment. Investigators should confirm that these 2 goals have been achieved by monitoring expectation of benefit with a treatment credibility questionnaire, measuring changes in process variables (variables that reflect the presumed mechanism of treatment), and monitoring differential dropout rates.
登录
查看更多内容
女性压力性尿失禁的保守治疗：随机临床试验的系统评价。
DOI：
10.1046/j.1464-410x.1998.00730.x
发表时间：
1998
期刊：
British Journal of Urology
影响因子：
--
作者：
Berghmans;Hendriks;Bø;Hay‐Smith;D. Bie;Van Waalwijk van Doorn
通讯作者：
Van Waalwijk van Doorn
大便失禁和便秘的生物反馈：医疗管理和教育的作用
影响因子：
29.4
作者：
S. Heymen;Kenneth r. Jones;Y. Ringel;Y. Scarlett;D. Drossman;W. Whitehead
通讯作者：
W. Whitehead
影响因子：
105.7
作者：
FREEMAN, RM;BAXBY, K
通讯作者：
BAXBY, K
女性尿失禁的保守治疗[J].
DOI：
--
发表时间：
1987
期刊：
Ugeskrift for læger
影响因子：
--
作者：
L. Heisterberg;J. Molin;A. Steen;Gjørup Pa
通讯作者：
Gjørup Pa
心理治疗和 SSRI 抗抑郁药治疗严重肠易激综合征的成本效益
影响因子：
29.4
作者：
F. Creed;L. Fernandes;E. Guthrie;S. Palmer;J. Ratcliffe;N. Read;C. Rigby;D. Thompson;B. Tomenson
通讯作者：
B. Tomenson